How to Start Your Own CGM Brand: Costs, MOQ and Timeline
2026-10-13 · Verid Bio
Every week, someone in the CGM business hears a version of the same question: "We have distribution in our market. Can we actually put our own brand on a glucose monitor?"
The honest answer has three parts: yes, the model exists; the cost is lower than you fear and higher than a website; and the difference between a successful launch and an expensive lesson is almost always the preparation done before the first purchase order.
This article is the roadmap we wish every first-time CGM brand owner had before signing anything — the models available, what each one realistically costs, the order quantities involved, a 12-month timeline, and the mistakes that kill entrants.
Verid Bio was the first CGM provider to enable SKD/CKD production models overseas. We have watched this market from the factory side for years — including watching well-funded brands fail for predictable reasons.
First, pick your model: five ways into the CGM market
"Starting a CGM brand" means different things depending on how much of the value chain you want to own. The five practical entry points, from lightest to heaviest:
| Model | What you do | Capital needed | Time to market | Best for |
|---|---|---|---|---|
| Resale / distribution | Sell an existing brand | Low | Weeks | Testing demand in your market |
| Private label | Brand an existing validated system | Low–medium | Months | Owning the brand quickly |
| OEM / ODM | Customize a platform to your spec | Medium | Medium | Specific product requirements |
| SKD / CKD | Assemble kits locally | Medium–high | Longer | Tenders, local-content rules, tariffs |
| Ground-up development | Build the sensor yourself | Very high | Years | Nobody, honestly, in year one |
The detailed trade-offs between OEM, SKD and CKD are covered in our manufacturing model comparison. For most first-time brand owners, the real decision is between resale (fast, but you build someone else's brand) and private label (slightly slower, but every customer you win is permanently yours).
The private label route is explained in depth in private label CGM; the rest of this article assumes that is the direction you are leaning.
What it actually costs
Nobody can give you a single number, because the cost depends on your market's registration path, your volumes and how deep your customization goes. But the shape of the cost is consistent, and understanding it will protect you from the two classic mistakes: comparing only unit prices, and budgeting only the unit prices.
Layer 1 — Program setup. Brand identity on packaging and hardware, app branding, translated materials, and regulatory documentation packages. This is a one-time cost, and on serious platforms it is usually the smallest of the three layers.
Layer 2 — Inventory. Your first orders. This is where MOQ (minimum order quantity) matters, and where undercapitalized launches die: the product is not a one-time purchase but a repurchase product, and your customers will expect sensor availability for years. Model your cash flow across at least four replenishment cycles, not just the first order.
Layer 3 — Market entry. Local registration or licensing, import duties, any in-country testing, and the commercial machinery of a launch: marketing, clinical relationships, service.
When you compare manufacturer quotes, normalize all three layers at your realistic first-year volume. A quote with a low unit price and silent program costs will lose, on paper, to a quote that is honest about both — until month four, when the difference shows up in your bank account.
MOQ: the question behind the question
First-time buyers ask about minimum order quantities the way people ask about the price of a house — hoping for one number that decides everything. The better questions are:
- What is the minimum for the first order, and what flexibility exists while the market is being validated?
- What is the realistic reorder cadence, and what happens to unit pricing as volume grows?
- What is the minimum for branded packaging runs, and can early orders share standard packaging?
A manufacturer that answers these without flinching is one that has done private label programs before. A manufacturer that only quotes a single large MOQ is telling you their program was built for one type of customer, and it is probably not you.
Be equally honest with yourself on the demand side: your first-order quantity should reflect a defensible forecast, not enthusiasm. Unsold CGM inventory is not a discount you can wait out — sensors are sterile medical products with expiry dating.
The 12-month timeline
Every market differs — the registration path is usually the long pole — but a typical private label first year looks like this:
| Phase | Months | What happens |
|---|---|---|
| Selection & diligence | 1–2 | Manufacturer shortlist, sample requests, document review, reference calls |
| Registration path | 2–5 | Confirm the classification and licensing route in your market; start paperwork early |
| Branding & configuration | 2–4 | Packaging, hardware branding, app branding, clinical configuration — overlaps with registration |
| Sample evaluation | 3–5 | Real-world wear testing by your team and friendly clinicians; judge the whole experience, not just accuracy |
| First order & launch | 5–8 | Production, shipping, launch channel activation |
| Reorder & scale | 8–12+ | First reorder decision, channel expansion, model migration (e.g. toward SKD) |
Notice that the phases overlap. The brands that launch fastest are the ones that run branding and registration in parallel instead of sequentially.
The five mistakes that kill first-time CGM brands
1. Buying on accuracy claims alone. Every platform quotes a MARD figure; few volunteers the study behind it. Insist on seeing the trial design — subject count, duration, reference method, glycemic coverage. Our MARD explainer tells you what a good answer contains.
2. Ignoring wear time. Accuracy on day 3 is easy; adhesive performance on day 13 of a 15-day sensor is where brands lose customers one complaint at a time. Ask explicitly how wear time was validated and what real-world sensor survival looks like.
3. Underestimating the software. The app is the product experience for most users. A sensor that pairs unreliably, or an app that crashes, will burn your brand faster than any accuracy statistic. Test the app on both major platforms, in your language, before you commit.
4. Budgeting for one order. A CGM brand is a subscription-shaped business wearing a hardware costume. If your plan only funds the first purchase order, you have a marketing event, not a business.
5. Choosing a manufacturer without a roadmap. Your platform will need algorithm updates, app maintenance and eventually successor hardware. Ask where the product line goes over the next three years. A manufacturer without an answer is selling you their tail-end inventory.
Why the window is open now
Two structural shifts make this a reasonable moment to enter, and both are covered in more depth in the regional era of CGM manufacturing:
- Demand is broadening beyond type 1 diabetes into type 2 management, metabolic health and wellness — customer segments that established brands serve poorly and regional brands can serve well.
- The manufacturing ecosystem has matured: validated platforms, app frameworks and regulatory documentation packages now exist off-the-shelf, which is precisely what makes private label and SKD models viable.
Windows like this close when the regional brands that moved early consolidate their markets. The cost of entering late is not higher prices — it is competing against brands that spent the last two years building pharmacist and clinician relationships.
What to do this week
If you are serious, the sequence is short:
- Write down your market, your regulatory status, and a defensible first-year volume estimate.
- Shortlist manufacturers who offer more than one model (private label through SKD) — it means they can grow with you instead of outliving your stage.
- Request samples and the documentation list from each; judge the documents as hard as the hardware.
- Talk to at least one reference customer per manufacturer.
Send your market, regulatory status and volume estimate to contact@verid.bio and we will tell you which of the five models fits — including the honest answer that sometimes it is not private label.